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Abstract
The oxidative stress at newborns is augmented by different conditions like preterm birth, 
asphyxia, respiratory distress, and intraventricular hemorrhage. Preterm neonates associ-
ate a more pronounced oxidative stress than healthy term newborns. Several neonatal 
conditions like respiratory distress (RDS), asphyxia, intraventricular hemorrhage, bron-
chopulmonary dysplasia, retinopathy, and necrotizing enterocolitis will increase the oxi-
dative stress. The harmful effects of free radicals are linked to their capacity to react with 
polyunsaturated fatty acids of cell membranes, proteins, and nucleic acids. Free radicals 
will produce protein alteration with function loss and lipid peroxidation.
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1. Introduction
Oxidative stress represents all injuries caused by reactive oxygen species (ROS) on biomol-
ecules, inducing the destruction of membranes, enzymes, receptors, as well as alteration of 
cell function. The consequence of oxidative stress is a disruption of the physiological balance 
between pro-oxidants and antioxidants [1, 2].
Newborn possesses defense mechanisms such us molecules protection, limitation of ROS 
production, and mechanisms for repair and adaptation to endogenous and exogenous ROS 
overproduction.
Reactive oxygen species are involved in physiological processes such as physical exercise, 
hyperbarism, regulation of vascular tone, stimulation of cell growth and proliferation, stimu-
lation of erythropoietin secretion, the learning and memory process, as well as in pathological 
processes: inflammation, aging, carcinogenesis [1–3].
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the t rms of the Crea ive
Comm ns Attribution Lic nse (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
In neonatal pathology, there are multiple circumstances that are associated with oxidative 
stress. An excess of reactive oxygen species in the context of immature, deficient antioxidant 
defense mechanisms may cause multisystemic diseases [2, 3].
1.1. Effects of reactive oxygen species on biomolecules
Reactive oxygen species will act on molecules, inducing their deterioration as follows:
• DNA lesions—action on the bases in the DNA structure—thymine, cytosine, adenine, gua-
nine, deoxyribose, followed by cell damage and mutations
• Alteration of NADPH—inhibition of the nucleotide coenzyme activity
• Lipids and proteins—action on the covalent bond in their structure
• Glycoproteins—action on hyaluronic acid in their structure
• Lipid peroxidation—structural and functional changes in cell membranes
1.1.1. Effects of oxidative stress on proteins and amino acids
Reactive oxygen species (ROS) act on the side chain of amino acids. Through oxidation of 
amino acids in the structure of proteins, the following changes are induced: protein fragmen-
tation, aggregation, and proteolytic degradation. Aldehydes resulting from lipid peroxidation 
and glycosylation will also act on proteins. The consequence will be the functional alteration 
of proteins, with the loss of their contractile, enzymatic, and transport function.
1.1.2. Effects of oxidative stress on lipids
The most extensively studied action on lipids is their cellular and extracellular peroxidation. 
Lipids and lipoproteins are involved, particularly those mainly composed of polyunsaturated 
fatty acids (PUFA) such as linoleic and arachidonic acids, abundantly in cholesterol esters, 
lecithin, and erythrocytic phospholipids. Lipoproteins can be oxidized by two pathways:
• Specific enzymatic oxidation—with the formation of prostaglandins, thromboxane, prosta-
cyclin, leukotrienes, and isoprostanes
• Nonspecific enzymatic oxidation—a peroxidation process with the formation of products 
with a damaging effect.
As a result of lipid peroxidation, a disorganization of the cell structure occurs, lipids being 
part of the membrane structure. A more rigid membrane will develop, with implications on 
essential membrane proteins, such as Na+-K+-dependent ATPase. Thus, a change in the ion 
pump rate will occur.
Lipid peroxides alter the properties of cellular, mitochondrial, and lysosomal membranes, 
with the disappearance of osmotic, chemical, and electrical gradients. Thus, cell excitability 
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and metabolic processes are disturbed, and morphological lesions occur. In the nerve fiber, 
the myelin sheath is attacked. At pulmonary level, there is an alteration of endothelial mem-
brane permeability, with the movement of lipids from the vascular space to the extravascular 
(interstitial) and intracellular space, and the development of pulmonary edema.
1.1.3. Effects of oxidative stress on carbohydrates
Glucose and monosaccharide oxidation leads to the formation of activated molecules that 
may interact with other molecules, generating new compounds. By polysaccharide oxidation, 
structural changes in deoxyribonucleic acid (DNA) may occur.
1.1.4. Effects of oxidative stress on nucleic acids
The number of oxidative attacks on DNA in humans is 10,000/cell. Thus, chromosome 
fragmentation occurs. Double-chain DNA is much more vulnerable than single-chain 
DNA. Altered fragments are eliminated as purine and pyrimidine bases by urinary excretion 
and they can be dosed. Oxidative DNA lesions accumulate with age. Aging and carcinogen-
esis are explained by incomplete DNA repair after oxidative attacks.
The superoxide anion resulting from the xanthine/xanthine oxidase system induces DNA 
breaks. The hydroxyl radical through its instantaneous reaction with nucleic acids also causes 
DNA breaks. These breaks should be normally repaired by cell enzymes, but due to their low 
fidelity, the repair process is inadequate through the inclusion of inappropriate bases in the 
DNA structure.
Oxygenated water also has effects on DNA. Through its reaction with DNA-bound metal 
ions, oxygenated water will induce the formation of hydroxyl radical, which will immediately 
fragment the DNA molecule.
2. Oxidative stress in newborns
The literature currently speaks about free radical disease in newborns, a term introduced by 
Sullivan [2], which includes the following pathogenic conditions: bronchopulmonary dyspla-
sia (BPD), retinopathy of prematurity (ROP), intra-periventricular hemorrhage (IPVH), necro-
tizing enterocolitis (NEC), and renal failure [1]. Premature newborns with a gestational age of 
less than 30 weeks and a weight of less than 1500 g, respectively, have a major risk to develop 
these disorders. At cerebral level, there is a predisposition to oxidative stress, due to the high 
amount of polyunsaturated fatty acids in the immature brain, particularly in neuronal mem-
branes, but also due to the relatively high amount of protein-unbound iron [41]. Immaturity 
associated with premature birth and also oxygen therapy used for the treatment of respira-
tory distress significantly increase oxidative stress in premature newborns. The knowledge of 
oxygen toxicity mechanisms is important both for their prevention and to ensure a harmoni-
ous development of newborns in general and premature newborns in particular, given their 
low antioxidant defense capacity [1, 3].
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2.1. Implication of oxidative stress in pulmonary disorders
Respiratory distress due to surfactant deficiency is one of the most frequent disorders in 
premature newborns. The higher the degree of prematurity, the higher is the incidence and 
severity of this disease. Due to the immature lung structure, surfactant deficiency, pulmonary 
fluid retention, and poorly developed bone and muscle structures, there is an increased sus-
ceptibility of the premature to pulmonary lesions. The mechanism of these pulmonary lesions 
is based on alveolar instability and pulmonary atelectasis.
Mechanical ventilation, in addition to its role of ensuring an adequate oxygen supply to the 
body, also has undesired effects. Thus, it interferes with inflammatory cell metabolism and 
pulmonary mediators. Pulmonary vascularization is supplied from the heart but is also a 
reservoir of neutrophils—1/3 of the total number of neutrophils outside the bone marrow is 
found in the lungs [38].
Animal experiments have evidenced that in the context of mechanical ventilation, the num-
ber of neutrophils and the level of mediators, platelet activating factors, thromboxane B2 in 
pulmonary lavage fluid, and TNF-alpha in alveolar macrophages increase [11]. In premature 
animals with RDS, mechanical ventilation will cause an increase in pulmonary inflammation 
mediators, an increase in granulocytes, and cytokine activation [8]. Ventilatory support may 
affect the alveolar-capillary barrier and induces a release of inflammation mediators from the 
alveolar space into the circulation. The translocation of endotoxins from the aerial space to the 
circulatory space will generate a systemic inflammatory response [8, 9].
Mechanical ventilation along with oxygen supplementation will generate oxidative stress, 
with protein oxidation under the action of ROS. The carbonyl group of proteins will react 
with 2,4-dinitrophenylhydrazine, and 2,4-dinitrophenyl-hydrazone will form, which is mea-
sured by spectrophotometry [16]. Prematures who develop bronchopulmonary dysplasia 
(BPD) have significantly higher levels of protein carbonyls during the first week of life [1, 16].
Newborns requiring mechanical ventilation are more exposed to free radical production as a 
result of oxygen therapy exposure, inflammatory response, and ischemia reperfusion [10, 49].
Experimentally, it has been demonstrated on animals that the synthesis of enzymatic and con-
sequently, antioxidant systems occurs at the end of gestation. Hemolysis after birth associated 
with a low level of iron-binding antioxidants can favor protein damage [5].
Protein carbonylation in the tracheobronchial fluid is a marker of oxidative stress at pulmo-
nary level, while the exhalation of lipid peroxidation products (ethane, pentane) is a marker 
of lipid peroxidation in the entire body. As a result, a high level of exhaled peroxidation prod-
ucts is associated with extrapulmonary morbidity [9, 10].
Enzymes protecting against oxidant agents in the lungs, such as catalase, can be the target 
of oxidative attack inducing their inactivation. Liposoluble free radical scavengers such as 
tocopherol or beta-carotene have a protective effect against oxidative attack on lipids, but not 
on proteins. At the end of the first week of life, a depletion of these scavengers occurs as a 
result of the rapid increase in ROS production under the action of pulmonary inflammatory 
response. Thus, lipid peroxidation products are released through oxidation of polyunsaturated 
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fatty acids. During the first 3–4 days of life, pulmonary proteins are the first target of free radi-
cals. In the context of RDS, edema develops as a result of increased membrane permeability. 
Due to its high protein content, its presence in the lung will make it the ideal target for the 
initiation of oxidative attack by ROS [30, 31]. The inactivation of α
1
-proteases under the action 
of oxidative attack will disrupt the balance of the pulmonary protease-antiprotease system. In 
infants with RDS, ROS will interact with the surfactant as well as with other proteins and lipid 
structures, delaying the normalization of pulmonary function [2, 5, 38].
Patients with respiratory distress have high levels of hydrogen peroxide in the pulmonary 
condensate. Oxidized glutathione and the altered alpha-1 protein also show high levels in 
the pulmonary fluid. In addition, the antioxidant proteins catalase and ferritin are elevated, 
which could represent a compensatory response. Oxidative stress markers are also increased 
in patients with sepsis, in those infected with HIV [40].
With the increase in the survival rate of newborns with extreme prematurity, the incidence 
of chronic pulmonary disorders has also increased, not only as an undesired consequence of 
RDS, but also of mechanical ventilation used for its treatment. The most frequent chronic pul-
monary disease of premature infants with RDS and a history of mechanical ventilation is bron-
chopulmonary dysplasia. This is a chronic lung disease developing in newborns treated with 
oxygen and mechanical ventilation for a primary pulmonary disease. It affects between 20 and 
60% of prematures, but it may also occur in term infants with severe respiratory distress [8].
Its etiopathogeny is complex. There is the hypothesis that bronchopulmonary dysplasia 
might start as an acute inflammation, which subsequently turns into a chronic lung disease 
under the action of free radicals [2, 5].
Preliminary studies have shown that pulmonary lesions can be improved by administration 
of antioxidants such as superoxide dismutase (SOD). The function of SOD is to convert the 
extremely toxic superoxide radical to less toxic hydrogen peroxide and water. Superoxide 
dismutase is also present naturally, but not as synthetic surfactant. Genetic engineering has 
demonstrated that in alveolar cells, SOD survives for a longer time period. An experimental 
animal with an SOD gene disrupted by genetic engineering, exposed to hyperoxia, will sur-
vive for a shorter time and will have more pulmonary lesions than an animal with an intact 
gene. Superoxide dismutase plays a major role in the prevention of pulmonary lesions in the 
context of hyperoxia. If SOD activity is increased in the newborn lung, inflammatory changes 
and pulmonary lesions can be prevented [9, 20, 21].
The incidence of bronchopulmonary dysplasia has increased not only with the extensive use 
of positive pressure ventilation for the treatment of neonatal respiratory distress, but also due 
to the increase of the survival rate by modern intensive care techniques in newborns with 
extreme prematurity. The Neonatal Research Network reported a 68% incidence of BPD in 
prematures with a gestational age of 22–28 WA.
Today, it is known that barotrauma, particularly at high inspiratory pressures, is a key fac-
tor in the development of pulmonary lesions independently of any other lesions generated 
by oxygen therapy. Epithelial alterations in the airways occur, as well as with an increase in 
capillary permeability with extravasation of protein substances. In addition to the implication 
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of high inspiratory pressure in the genesis of pulmonary lesions, increased tidal volume also 
plays an important role. High but also significantly decreased tidal volume may generate an 
accumulation of neutrophils and a release of toxic agents such as proteases and free radicals, 
as well as proinflammatory cytokines. An analysis of pathological anatomy data has allowed 
to evidence a correlation between the incidence of interstitial emphysema during the first 
week of life and the incidence of interstitial fibrosis or proliferation in newborns with bron-
chopulmonary dysplasia surviving for more than 28 days [22, 24].
Another factor that plays a role in the development of BPD is inflammation. Proinflammatory 
cytokines were detected in the tracheal aspiration fluid during the first 1–2 weeks of life in 
newborns who subsequently developed BPD. Recently, it has been demonstrated that amnio-
nitis and fetal infection are risk factors for BPD; consequently, inflammation, even prenatal, 
plays a role in its genesis [3].
Premature infants, due to their pulmonary immaturity, have a high risk for BPD, because 
they require additional oxygen supply for a longer time period in the treatment of the lung 
disease, their intracellular antioxidant defense capacity is affected, and they have an increased 
susceptibility to infections.
Studies have demonstrated the presence of a high level of lipid peroxidation products on days 
1–2 of life in newborns who develop BPD. The presence of a high level of protein peroxidation 
products in the tracheal aspirate of infants weighing less than 1500 g compared to those with 
a higher weight has also been demonstrated. This confirms the fact that antioxidant defense 
decreases with the increase of immaturity [9, 15, 16].
There is also a close correlation between the protein oxidation level and activated neutrophils. 
This supports the presence of a relationship among neutrophil accumulation, oxidative stress, 
and the development of BPD [1].
In randomized trials for the study of STOP-ROP, some authors monitored oxygen exposure 
and the evolution of retrolental fibroplasia and BPD [36]. Thus, in groups with 89–94% O
2
 
Sat, compared to those with 96–99% O
2
 Sat, the influence of saturation on the progression of 
retrolental fibroplasia was not significant. In contrast, in the group with higher saturation, the 
BPD progression rate was higher (13.2%) compared to subjects exposed to lower saturation 
levels (8.5%) [23, 39].
Exposure to a FiO
2
 of 100% on the first day practically doubles the risk of BPD. Excessive oxy-
gen administration and/or barotrauma may increase the risk of BPD. However, a high PaO
2
 is 
a cofactor, not a causal agent in the development of BPD [36].
Preterm birth associates vitamin A deficiency, which is important in pulmonary epithelial 
lesion repair. A number of studies have evidenced a significant reduction in the incidence of 
bronchopulmonary dysplasia under conditions of vitamin A administration (Shenai et al.) 
[34, 37], but there are also studies that could not demonstrate this fact (Perason et al.) [32, 33].
Selenium deficiency can also be considered in association with low glutathione levels. Darlow 
et al. found a significant relationship between plasma selenium levels and the incidence of 
bronchopulmonary dysplasia at the age of 28 days, but could not clarify whether these were 
a cause or an effect of BPD.
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A study conducted in our department, which assessed lipid peroxidation by measuring malondi-
aldehyde (MDA) levels on the first and third days of life found that MDA values in newborns with 
respiratory distress increased with the increase in the severity of respiratory distress (Table 1).
MDA values in the mentioned study tended to decrease on day 3 compared to day 1, but 
without a statistically significant difference.
Also, the lipid peroxidation process was more intense in the study group-newborns with dif-
ferent pathologies generating oxidative stress compared with the control group of  healthy 
term newborns, without any oxidative-stress inducing disorders (Figures 1 and 2).
In the same study, we also monitored protein peroxidation in newborns with respiratory dis-
tress, and we found the presence of a significant correlation between protein carbonyl values 
on the third day of life and respiratory distress (r = 0.56; p < 0.05). For the evaluation of protein 
peroxidation in the mentioned study, we measured protein carbonyls on the first and third 
days of life using the Reznick spectrophotometric method with dinitrophenylhydrazine. The 
protein substrate in the lung is an optimal target for the action of ROS and the triggering of 
oxidation reactions of these proteins. In fact, it was demonstrated that in newborns with RDS, 
this protein oxidation process under the action of ROS also contributes to the pathogenesis 
of BPD. Under the action of reactive oxygen species, peroxidation of proteins and other lipid 
and protein structures occurs. Thus, the normalization of pulmonary function is delayed. 
Surfactant administration before the initiation of mechanical ventilation limits oxidative 
injury induced by mechanical ventilation.
2.2. Effects of oxidative stress at endothelial level
The effects of ROS at endothelial level during the neonatal period are found in the following 
morbid conditions: septic shock, systemic inflammation, acute ischemia, inducing consider-
able oxidative stress [5]. Reactive oxygen species contribute to the development of ischemic 
and inflammatory vascular lesions by an important efflux of oxidants to the ischemic tissue 
and the induction of new lesions in tissues and organs in the next reperfusion stage [29].
RankSum1 RankSum2 U p n1 n2
RDS mild vs. severe MDA DOL 1 255.0 273.0 84.0 0.1159 18 14
MDA DOL 3 281.0 247.0 110.0 0.5611 18 14
RDS mild vs. moderate MDA DOL 1 307.5 638.5 136.5 0.0283 18 25
MDA DOL 3 379.0 567.0 208.0 0.6877 18 25
RDS severe vs. moderate MDA DOL 1 75.5 114.5 23.5 0.1740 6 13
MDA DOL 3 79.0 111.0 20.0 0.0956 6 13
MV yes vs. no MDA DOL 1 376.5 1453.5 285.5 0.7229 13 47
MDA DOL 3 407.5 1422.5 294.5 0.8454 13 47
RDS = respiratory distress syndrome, MV = mechanical ventilation, RankSum = rank sum, p = test sign, and n = group size.
Table 1. MDA values according to RDS severity.
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Figure 1. MDA values of case group DOL 1 vs. control group (caz = case, mar = control).
Figure 2. MDA values of case group DOL 3 vs. control group (caz = case, mar = control).
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The vascular surface has the role to control critical processes for the functioning of organs. 
During inflammatory processes, the endothelium is exposed to oxidation [25]. It has been 
demonstrated that TNF-alpha stimulates the release of oxygenated water at the contact area 
between neutrophils and the endothelial cell, inducing endothelial cell retraction.
The exposure of endothelial cells to significant concentrations of exogenous oxidants will cause 
specific physiological effects. Endogenous oxidants have been recognized as a physiological 
signal component, probably triggered by lung injury, with the release of TNF-alpha, interleu-
kin, growth factor β, and platelet growth factors. These will stimulate tyrosine phosphoryla-
tion, with the activation of ERK, extracellular signal-regulated kinase. DNA synthesis will 
occur accompanied by an increase in hydrogen peroxide levels. Oxidants mediate the effects 
of growth factors β and insulin, which will stimulate mitogen-activated proteins [27–28].
2.2.1. Oxidative stress in retinopathy of prematurity
The harmful effects of ROS at endothelial level also manifest in ROP [10, 23]. In the pathogen-
esis of ROP, the following factors are involved: self-regulation, which is absent in newborns, 
hyperoxygenation of the retina, which is frequent because antioxidant defense is reduced, par-
ticularly in the premature. Hyperoxygenation induces peroxidation of vasoactive isoprostanes. 
Vasoconstriction and vascular cell toxicity with ischemia and vascular proliferation occur [4, 7].
Glutathione is the most important intracellular antioxidant; however, its synthesis is reduced 
during intrauterine life and in prematures. In the vitreous fluid of the premature at risk for 
retinopathy, there is a high level of hypoxanthine with a role in the formation of free radicals 
[1, 12]. Papp et al. [6] found that the oxidized glutathione/reduced glutathione ratio is more 
than double in prematures with retinopathy compared to those without this disease. This is 
why the problem of using this ratio as a screening method for the detection of ocular involve-
ment in premature infants was posed. The same authors found that in infants with active 
disease aged less than 3 months, reduced glutathione values were lower, and those of oxi-
dized glutathione were higher, the greatest decrease in reduced glutathione occurring after 
the in vitro alteration of oxidative status.
2.2.2. Effects of oxidative stress in ulceronecrotic enterocolitis
In ulceronecrotic enterocolitis, there are multiple pathogenic mechanisms. One of the patho-
genic links is hypoxic ischemic injury. Hypoxic ischemic injury in the mesentery is followed 
by a cascade of events, with intestinal mucosal reperfusion injury. Cytotoxic damage of vas-
cular endothelial cells occurs, which in turn will cause ischemia and new cytotoxic effects 
through the formation of free radicals [41].
The regulation of mesenteric blood flow includes a reflex self-regulation mechanism. The 
peripheral autonomic nervous system plays a role in the regulation of mesenteric blood flow.
The initiated ischemia will induce transcapillary fluid passage and local edema. Reperfusion 
will exacerbate transcapillary fluid production and induce tissue destruction. This event is 
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mediated by factors released from the ischemic intestine, including endotoxins, histamine, 
prostaglandins, and superoxide anion, which result from oxygen metabolization. Superoxide 
will induce lipid peroxidation with the disruption of the integrity of capillaries and epithelial 
cells. Mucosal lesions characterized by edema, hemorrhage, ulceration, and necrosis may be 
induced experimentally by a combination of oxidants (hypoxanthine and xanthine oxidase) 
[14]. Superoxide dismutase can experimentally prevent or attenuate the described lesions. 
The protective effect of SOD was experimentally observed in animals with superior mesen-
teric artery occlusion. The sequential development of intestinal enzymes: SOD and xanthine 
oxidase can be a determining factor of neonatal intestinal susceptibility to ischemic mucosal 
injury [13, 45]. Regarding NEC prevention, many studies performed on animals show the 
beneficial effect of melatonin in preventing oxidative stress involved in the development of 
NEC lesions. Melatonin acts by reducing the level of inflammatory cytokines and by stimulat-
ing the activity of antioxidant enzymes. A decrease in TNF-α and IL-1β levels was found in 
animals treated with melatonin. Melatonin also counteracts the reduction of intestinal motil-
ity generated by lipopolysaccharides. Melatonin is an indolamine produced by the pineal 
gland, having serotonin as a precursor. It is synthesized by serotonin-rich enterochromaffin 
cells in the digestive tract. This synthesis takes place postprandially in the digestive tube and 
its level is 100 times higher than blood levels [45, 46].
The pathophysiological mechanism of NEC is based on a hypoxic-ischemic process similar 
to that found in postasphyxia brain injury. A number of studies have demonstrated that the 
association of melatonin with misoprostol, a gastric mucosal protective agent, is more ben-
eficial than melatonin therapy alone. These studies on animals found that the administration 
of 10 mg/kg body weight melatonin for 3 days to animals with induced NEC-like lesions 
significantly reduced the severity of the disease by decreasing cytokine levels and stimulating 
antioxidant enzyme activity [45, 48].
2.2.3. Effects of oxidative stress in neonatal asphyxia and hypoxic ischemic encephalopathy
In the brain, there are some particularities that increase the vulnerability of this tissue to 
oxidative stress: cell membranes are rich in polyunsaturated fatty acids, the brain is poor in 
catalase and SOD, and there are some brain areas rich in iron. Nerve cell injury in the context 
of asphyxia will induce iron release [13]. Given the low antioxidant defense, the release of 
low molecular mass iron will allow the formation of hydroxyl radical and lipid peroxidation. 
By lipid peroxidation, free radicals induce molecular damage, including endothelial factor 
destruction. The low level of antioxidants in the serum seems to be directly involved in the 
genesis of cerebral hemorrhage [17]. Transferrin and ceruloplasmin levels can be indicators 
of the risk of cerebral hemorrhage in newborns with asphyxia at birth [17, 18]. In prematures 
with asphyxia, a decrease in these enzymes will precede cerebral hemorrhage. Ceruloplasmin 
acts as a strong ferroxidase, catalyzing iron oxidation to less reactive ions. The antioxidant 
defense capacity can be exceeded, making transferrin inadequate for binding, with the release 
of low molecular mass iron, which will subsequently induce lipid peroxidation. In case of iron 
overloading or severe oxidative stress, the antioxidant defense capacity is exceeded, making 
nontransferrin bonds available, with the release of low molecular mass iron, followed by lipid 
peroxidation. This may occur even if transferrin is not completely iron saturated [42].
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Hypoxic ischemic brain injury is a long process that starts with the occurrence of the insult 
and continues during the recovery period, after reperfusion. This reperfusion process repre-
sents a paradoxical tissue response: the appearance of oxidative lesions in a hypoxic tissue, 
poorly perfused after circulatory stabilization, at the time of its perfusion with oxygenated 
blood. This stage of reperfusion will cause an excessive production of free radicals generating 
new lesions after the initial oxidative attack. In the premature, an increased risk of cerebral 
ischemia persists postnatally, during the first week of life [19, 26, 27].
In the reperfusion stage, ROS with a cell damaging effect are produced, in the first place by the 
conversion of xanthine dehydrogenase to xanthine oxidase. This process will result in the for-
mation of thiol groups or proteolysis by activation of proteases in energetically depressed cells. 
In the reoxygenation stage, hypoxanthine is converted to uric acid under the action of xanthine 
oxidase, and superoxide and peroxide are released through the mediation of xanthine oxidase 
by molecular oxygen binding. Hydroxyl radical generated through the Fenton reaction will also 
be released, due to the catalytic effect of metals such as iron [42]. Perinatal hypoxic stress is a 
frequent cause of morbidity, mortality, and neurological damage in survivors. In the perinatal 
hypoxic context, several factors play a role in the pathogenesis of lesions: hypoxia with initial 
ROS formation, followed by ischemia-reperfusion, a stage at which arachidonic acid and phago-
cytes will be activated under the action of inflammation mediators. Thus, a vicious circle is cre-
ated. ROS will be formed, followed by tissue lesions and the genesis of new free radicals [42, 43].
At CNS level, under asphyxia conditions, encephalopathy lesions are induced by activation 
of leukocytes or glial cells and release of new free radicals. Hypoxic lesions will be perpetu-
ated by release of protein-unbound iron. Endothelial lesions, hemostasis abnormalities, and 
inflammatory lesions occur, as well as with an increase in anaerobic metabolism, lactic acid 
levels, brain damage as a result of oligodendroglial vulnerability, astrocyte dysfunction, 
N-methyl-D-aspartate receptor abnormalities, and synaptic damage [28, 29].
Mitochondrial DNA damage induces changes in respiratory chain proteins, with the forma-
tion of new free radicals and subsequent cell lesions. Neonatal cerebral hypoxia stimulates 
activin secretion, which in turn stimulates erythropoietin, resulting in the production of 
nucleated red blood cells [35, 43].
The types of lesions that occur in the brain as a result of hypoxia are variable. In the extremely 
immature brain, preoligodendrocytes and cell precursors of oligodendrocytes are affected. As the 
brain matures, the resistance of oligodendrocytes to oxidative stress increases due to an increase 
in antioxidant defense, as well as to the protein structure involved in programmed cell death.
After the hypoxic episode, there is an increase in the density of glutamate receptors, and mito-
chondrial calcium accumulation occurs, which will trigger apoptosis. Caspase 6 and, sub-
sequently, caspase 3 are activated. NMDA receptor activation depresses the mitochondrial 
respiratory process and induces apoptosis—a process which is not found in adults, known as 
the NMDA paradox [41, 48].
Studies conducted by Peeters and Schulte regarding the activity of glutathione peroxidase 
in the cerebrospinal fluid of newborns with asphyxia and the neuron-specific enolase value 
evidenced a correlation between the glutathione peroxidase value and gestational age, as well 
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as between the neuronal enolase value and the neurological evolution of perinatal asphyxia 
cases. The influence of the genetic factor on postischemic evolution was also demonstrated, as 
well as on the presence of a correlation with patient’s sex, males being more predisposed to 
develop lesions compared to females.
With the stabilization of newborns with asphyxia at birth, in the reoxygenation stage, the 
exposure of the diseased cell to a new oxidative attack follows. The use of 100% oxygen in 
resuscitation is an important source for the formation of ROS. Hyperoxia causes an increase 
in the activity of antioxidant enzymes such as catalase or superoxide dismutase, as well as 
an activation of enzymes in the glutathione reductase cycle: GSH-reductase and GSH-S-
transferase. Some studies demonstrated that the urinary level of N-acetyl-glucosaminidase is 
correlated with the value of oxidized glutathione and is higher in newborns exposed to a FiO
2
 
of 100%. Based on these findings, resuscitation guidelines were changed in 2010, indicating to 
start neonatal resuscitation with atmospheric air, followed by an increase by titration in the 
FiO
2
 value depending on the improvement of blood oxygen saturation [1, 3, 43].
In the study conducted in our unit, we found that lipid peroxidation in newborns with 
asphyxia was maintained at a high level on the third day compared to the first day of life, 
without a statistically significant difference. This high plateau value on day 3 was attributed 
to perinatal hypoxic stress and to the reoxygenation-reperfusion process. None of the new-
borns with asphyxia received hypothermia treatment, because at the time of the study, this 
therapeutic method was not available in our unit. The analysis of lipid peroxidation after neo-
natal asphyxia by gestational age groups evidenced more intense peroxidation in premature 
infants compared to term infants with asphyxia. We explained this process by the associa-
tion of neonatal asphyxia with respiratory distress in the case of prematures, which involved 
oxygen therapy and respiratory support for its treatment, factors that increased oxidative 
stress and implicitly, malondialdehyde values. Regarding protein peroxidation, its markers 
are found in high amounts in the plasma of prematures with asphyxia. Their high values are 
maintained until the seventh day of life [43]. In newborns with hypoxic ischemic encephalop-
athy in our study, protein peroxidation was more intense compared to the other newborns. 
Hypoxic injury is aggravated by protein-unbound iron release. In its presence, as part of the 
Fenton reaction, hydroxyl radicals are released, which will exert a strong toxic effect on the 
brain. ROS toxicity in newborns is enhanced by the increased production of ROS, their rapid 
tissue growth, and impaired antioxidant defense. In the developing brain, endothelial lesions, 
hemostasis abnormalities, inflammatory reaction, an increase of anaerobic metabolism occur, 
which are followed by lactic acid accumulation. Oligodendroglial injury, astrocyte dysfunc-
tion, and synaptic abnormalities will result [43, 44].
Oxidative stress markers have an important predictive value for neuronal injury in newborns 
at risk. The correlation between the values of oxidative stress markers and imaging electro-
physiological brain changes, near-infrared spectroscopy (NIRS) aspects, and the degree of 
neurological impairment is not currently described in the literature. This is why further stud-
ies are required in this respect. Also, research on therapies protecting against cerebral oxida-
tive stress after perinatal asphyxia has not reported a clearly beneficial medication at this 
stage of knowledge. The only therapy currently applied with positive, beneficial results in 
perinatal asphyxia is controlled hypothermia. In the near future, studies are needed which 
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should attempt to identify free radical scavengers that can be administered to newborns and 
could be useful in limiting oxidative stress, particularly in prematures, in whom antioxidant 
defense is impaired due to the end of pregnancy before term [44, 47].
3. Conclusion
Oxidative stress at newborns has role in pathogenesis of different neonatal diseases. The oxi-
dative stress is more severe in preterm than in term neonates. The antioxidant defense of 
preterm less developed than in term neonates, mainly the enzymatic antioxidant defense.
In the near future, studies are needed which should attempt to identify free radical scavengers 
that can be administered to newborns and could be useful in limiting oxidative stress, particu-
larly in prematures, in whom antioxidant defense is impaired due to the end of pregnancy 
before term.
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